<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101589550</journal-id>
<journal-id journal-id-type="pubmed-jr-id">40869</journal-id>
<journal-id journal-id-type="nlm-ta">JAMA Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">JAMA Psychiatry</journal-id>
<journal-title-group>
<journal-title>JAMA psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">2168-622X</issn>
<issn pub-type="epub">2168-6238</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27074206</article-id>
<article-id pub-id-type="pmc">6353566</article-id>
<article-id pub-id-type="doi">10.1001/jamapsychiatry.2016.0144</article-id>
<article-id pub-id-type="manuscript">NIHMS995077</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Montano</surname>
<given-names>Carolina</given-names>
</name>
<degrees>BS</degrees>
<aff id="A1">Medical Scientist Training Program and Predoctoral Training Program in Human Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
<aff id="A2">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taub</surname>
<given-names>Margaret A.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A3">Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaffe</surname>
<given-names>Andrew</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A4">Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland</aff>
<aff id="A5">Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Briem</surname>
<given-names>Eirikur</given-names>
</name>
<degrees>MS</degrees>
<aff id="A6">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feinberg</surname>
<given-names>Jason I.</given-names>
</name>
<degrees>BS</degrees>
<aff id="A7">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trygvadottir</surname>
<given-names>Rakel</given-names>
</name>
<degrees>BS</degrees>
<aff id="A8">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Idrizi</surname>
<given-names>Adrian</given-names>
</name>
<degrees>BS</degrees>
<aff id="A9">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Runarsson</surname>
<given-names>Arni</given-names>
</name>
<degrees>BS</degrees>
<aff id="A10">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berndsen</surname>
<given-names>Birna</given-names>
</name>
<degrees>MS</degrees>
<aff id="A11">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gur</surname>
<given-names>Ruben C.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A12">Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Tyler M.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A13">Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perry</surname>
<given-names>Rodney T.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A14">Department of Epidemiology, University of Alabama at Birmingham, Birmingham</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fugman</surname>
<given-names>Doug</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A15">Rutgers University Cell and DNA Repository, Piscataway, New Jersey</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sabunciyan</surname>
<given-names>Sarven</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A16">Stanley Division of Developmental Neurovirology, Johns Hopkins, School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yolken</surname>
<given-names>Robert H.</given-names>
</name>
<degrees>MD</degrees>
<aff id="A17">Stanley Division of Developmental Neurovirology, Johns Hopkins, School of Medicine, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hyde</surname>
<given-names>Thomas M.</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A18">Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kleinman</surname>
<given-names>Joel E.</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A19">Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sobell</surname>
<given-names>Janet L.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A20">Department of Psychiatry and Behavioral Sciences, Keck School of Medicine of University of Southern California, Los Angeles</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pato</surname>
<given-names>Carlos N.</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A21">Department of Psychiatry and Behavioral Sciences, Keck School of Medicine of University of Southern California, Los Angeles</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pato</surname>
<given-names>Michele T.</given-names>
</name>
<degrees>MD</degrees>
<aff id="A22">Department of Psychiatry and Behavioral Sciences, Keck School of Medicine of University of Southern California, Los Angeles</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Go</surname>
<given-names>Rodney C.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A23">Department of Epidemiology, University of Alabama at Birmingham, Birmingham</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nimgaonkar</surname>
<given-names>Vishwajit</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A24">Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weinberger</surname>
<given-names>Daniel R.</given-names>
</name>
<degrees>MD</degrees>
<aff id="A25">Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Braff</surname>
<given-names>David</given-names>
</name>
<degrees>MD</degrees>
<aff id="A26">Department of Psychiatry, University of California San Diego School of Medicine, La Jolla</aff>
<aff id="A27">VISN22, Mental Illness Research, Education, and Clinical Center, VA Veterans Affairs San Diego Healthcare System, San Diego, California</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gur</surname>
<given-names>Raquel E.</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A28">Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fallin</surname>
<given-names>Margaret Daniele</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A29">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
<aff id="A30">Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feinberg</surname>
<given-names>Andrew P.</given-names>
</name>
<degrees>MD, MPH</degrees>
<aff id="A31">Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff>
<aff id="A32">Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland</aff>
<aff id="A33">Departments of Medicine and Biomedical Engineering, Johns Hopkins University School of Medicine and Whiting School of Engineering, Baltimore, Maryland</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1"><bold>Author Contributions:</bold> Ms Montano and Dr Taub had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr A. P. Feinberg and Dr Fallin cosupervised this work and contributed equally as principal investigators.</p>
<p id="P2"><italic>Study concept and design:</italic> Fallin, A. P. Feinberg.</p>
<p id="P3"><italic>Acquisition, analysis, or interpretation of data:</italic> Montano, Taub, Jaffe, Briem, J. I. Feinberg, Trygvadottir, Idrizi, Runarsson, Berndsen, R. C. Gur, Perry, Sabunciyan, Yolken, Hyde, Kleinman, Sobell, C. N. Pato, M. T. Pato, Go, Nimgaonkar, Weinberger, Braff, R. E. Gur, Fallin, A. P. Feinberg.</p>
<p id="P4"><italic>Drafting of the manuscript:</italic> Montano, Fallin, A. P. Feinberg.</p>
<p id="P5"><italic>Critical revision of the manuscript for important intellectual content:</italic> Montano, Taub, Jaffe, Moore, Perry, Sabunciyan, Hyde, Kleinman, Sobell, C. N. Pato, M. T. Pato, Go, Nimgaonkar, Weinberger, Braff, R. E. Gur, Fallin, A. P. Feinberg.</p>
<p id="P6"><italic>Statistical analysis:</italic> Montano, Taub, Jaffe.</p>
<p id="P7"><italic>Obtained funding:</italic> R. C. Gur, Nimgaonkar, Perry, Braff, A. P. Feinberg.</p>
<p id="P8"><italic>Administrative, technical, or material support:</italic> Briem, J. I. Feinberg, Trygvadottir, Idrizi, Runarsson, Berndsen, Fugman, Hyde, Kleinman, C. N. Pato, M. T. Pato, Sobell.</p>
<p id="P9"><italic>Study supervision:</italic> Fallin, A. P. Feinberg.</p>
</fn>
<fn fn-type="con" id="FN2">
<p id="P10"><bold>Additional Contributions:</bold> We thank Roxann Ashworth, MHS (Genetic Resources Core Facility, Johns Hopkins Institute of Genetic Medicine), for her expertise on genotyping. She was compensated for her work.</p>
</fn>
<corresp id="CR1"><bold>Corresponding Author:</bold> Andrew P. Feinberg MD, MPH, Johns Hopkins, University Schools of Medicine, Engineering, and Public Health, 855 N Wolfe St, Rangos 570, Baltimore, MD 21205, (<email>afeinberg@jhu.edu</email>).</corresp>
<fn fn-type="COI-statement" id="FN10">
<p id="P45"><bold>Conflict of Interest Disclosures:</bold> None reported.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>73</volume>
<issue>5</issue>
<fpage>506</fpage>
<lpage>514</lpage>
<!--elocation-id from pubmed: 10.1001/jamapsychiatry.2016.0144-->
<abstract id="ABS1">
<sec id="S1">
<title>IMPORTANCE</title>
<p id="P11">DNA methylation may play an important role in schizophrenia (SZ), either directly as a mechanism of pathogenesis or as a biomarker of risk.</p>
</sec>
<sec id="S2">
<title>OBJECTIVE</title>
<p id="P12">To scan genome-wide DNA methylation data to identify differentially methylated CpGs between SZ cases and controls.</p>
</sec>
<sec id="S3">
<title>DESIGN, SETTING, AND PARTICIPANTS</title>
<p id="P13">Epigenome-wide association study begun in 2008 using DNA methylation levels of 456 513 CpG loci measured on the Infinium HumanMethylation450 array (Illumina) in a consortium of case-control studies for initial discovery and in an independent replication set. Primary analyses used general linear regression, adjusting for age, sex, race/ethnicity, smoking, batch, and cell type heterogeneity. The discovery set contained 689 SZ cases and 645 controls (n = 1334), from 3 multisite consortia: the Consortium on the Genetics of Endophenotypes in Schizophrenia, the Project among African-Americans To Explore Risks for Schizophrenia, and the Multiplex Multigenerational Family Study of Schizophrenia. The replication set contained 247 SZ cases and 250 controls (n = 497) from the Genomic Psychiatry Cohort.</p>
</sec>
<sec id="S4">
<title>MAIN OUTCOMES AND MEASURES</title>
<p id="P14">Identification of differentially methylated positions across the genome in SZ cases compared with controls.</p>
</sec>
<sec id="S5">
<title>RESULTS</title>
<p id="P15">Of the 689 case participants in the discovery set, 477 (69%) were men and 258 (37%) were non–African American; of the 645 controls, 273 (42%) were men and 419 (65%) were non–African American. In our replication set, cases/controls were 76% male and 100% non–African American. We identified SZ-associated methylation differences at 923 CpGs in the discovery set (false discovery rate, &lt;0.2). Of these, 625 showed changes in the same direction including 172 with <italic>P</italic> &lt; .05 in the replication set. Some replicated differentially methylated positions are located in a top-ranked SZ region from genome-wide association study analyses.</p>
</sec>
<sec id="S6">
<title>CONCLUSIONS AND RELEVANCE</title>
<p id="P16">This analysis identified 172 replicated new associations with SZ after careful correction for cell type heterogeneity and other potential confounders. The overlap with previous genome-wide association study data can provide potential insights into the functional relevance of genetic signals for SZ.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>